Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Baker Hughes (BKR) Financials

Baker Hughes logo
$66.06 +0.26 (+0.40%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$66.00 -0.06 (-0.09%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Baker Hughes

Annual Income Statements for Baker Hughes

This table shows Baker Hughes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
0.00 0.00 -103 195 128 -9,940 -219 -601 1,943 2,979 2,588
Consolidated Net Income / (Loss)
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008 2,624
Net Income / (Loss) Continuing Operations
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008 2,624
Total Pre-Tax Income
-158 358 -335 680 753 -15,202 428 22 2,655 3,265 2,877
Total Operating Income
-138 457 -284 701 1,074 -15,978 1,310 1,185 2,327 3,122 3,342
Total Gross Profit
4,495 2,932 3,036 3,986 4,432 3,199 4,049 4,400 5,902 6,483 6,544
Total Revenue
16,688 13,082 17,179 22,877 23,838 20,705 20,502 21,156 25,506 27,829 27,733
Total Cost of Revenue
12,193 10,150 14,143 18,891 19,406 17,506 16,453 16,756 19,604 21,346 21,189
Operating Cost of Revenue
12,193 10,150 14,143 18,891 19,406 17,506 16,453 16,756 19,604 21,346 21,189
Total Operating Expenses
4,633 2,475 3,320 3,285 3,358 19,043 2,739 3,215 3,575 3,361 3,202
Selling, General & Admin Expense
2,115 1,926 2,535 2,699 2,832 2,404 2,470 2,510 2,611 2,458 2,387
Research & Development Expense
- - - - - - - - 651 643 600
Restructuring Charge
438 549 785 586 - 1,866 - - 313 260 215
Total Other Income / (Expense), net
-20 -99 -51 -21 -321 776 -882 -1,163 328 143 -465
Interest Expense
120 102 131 223 237 264 299 252 216 198 222
Other Income / (Expense), net
100 3.00 80 202 -84 1,040 -583 -911 544 341 -243
Income Tax Expense
473 173 45 258 482 559 758 600 685 257 253
Net Income / (Loss) Attributable to Noncontrolling Interest
-25 -69 -330 88 143 -5,821 -111 23 27 29 36
Basic Earnings per Share
$0.00 $0.00 ($0.24) $0.46 $0.23 $0.00 ($0.27) ($0.61) $1.93 $3.00 $2.62
Weighted Average Basic Shares Outstanding
- - 1.47B 427M 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M 988.24M
Weighted Average Diluted Shares Outstanding
- - 1.47B 427M 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M 988.24M
Weighted Average Basic & Diluted Shares Outstanding
- - 1.47B 427M 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M 988.24M
Cash Dividends to Common per Share
$0.00 - - $0.00 $0.72 $0.00 $0.72 $0.73 $0.78 $0.84 $0.92

Quarterly Income Statements for Baker Hughes

This table shows Baker Hughes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
518 439 455 579 766 1,179 402 701 609 876 930
Consolidated Net Income / (Loss)
524 451 463 581 774 1,190 409 711 617 887 938
Net Income / (Loss) Continuing Operations
524 451 419 581 774 1,190 409 711 617 887 938
Total Pre-Tax Income
759 522 641 824 1,009 791 561 967 821 528 1,274
Total Operating Income
714 651 660 845 930 665 752 887 948 755 772
Total Gross Profit
1,343 1,448 1,442 1,646 1,700 1,530 1,475 1,615 1,701 1,753 1,504
Total Revenue
6,641 6,834 6,418 7,139 6,908 7,364 6,427 6,910 7,010 7,386 6,587
Total Cost of Revenue
5,298 5,386 4,976 5,493 5,208 5,834 4,952 5,295 5,309 5,633 5,083
Operating Cost of Revenue
5,298 5,386 4,976 5,493 5,208 5,834 4,952 5,295 5,309 5,633 5,083
Total Operating Expenses
629 797 782 801 770 865 723 728 753 998 732
Selling, General & Admin Expense
627 634 618 643 612 585 577 567 607 636 562
Research & Development Expense
- - 164 158 158 - 146 161 146 147 133
Restructuring Charge
- - - - - - 0.00 - - - 37
Total Other Income / (Expense), net
45 -129 -63 -21 79 126 -191 80 -127 -227 502
Interest Expense
49 45 41 47 55 55 51 54 56 61 86
Other Income / (Expense), net
94 -84 -22 26 134 181 -140 134 -71 -166 588
Income Tax Expense
235 71 178 243 235 -399 152 256 204 -359 336
Net Income / (Loss) Attributable to Noncontrolling Interest
6.00 12 8.00 2.00 8.00 11 7.00 10 8.00 11 8.00
Basic Earnings per Share
$0.51 $0.44 $0.46 $0.58 $0.77 $1.19 $0.41 $0.71 $0.62 $0.88 $0.94
Weighted Average Basic Shares Outstanding
1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M 986.77M 988.24M 992.07M
Diluted Earnings per Share
$0.51 $0.43 $0.45 $0.58 $0.77 $1.18 $0.40 $0.71 $0.61 - $0.93
Weighted Average Diluted Shares Outstanding
1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M 986.77M 988.24M 992.07M
Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M 986.77M 988.24M 992.07M
Cash Dividends to Common per Share
$0.20 $0.20 $0.21 $0.21 $0.21 $0.21 $0.23 $0.23 $0.23 $0.23 $0.23

Annual Cash Flow Statements for Baker Hughes

This table details how cash moves in and out of Baker Hughes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
42 -451 5,997 -3,307 -474 883 -279 -1,365 158 718 351
Net Cash From Operating Activities
1,277 262 -799 1,762 2,126 1,304 2,374 1,888 3,062 3,332 3,810
Net Cash From Continuing Operating Activities
1,277 262 -799 1,762 2,126 1,304 2,374 1,888 3,062 3,332 3,810
Net Income / (Loss) Continuing Operations
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008 2,624
Consolidated Net Income / (Loss)
-631 185 -391 283 271 -15,761 -330 -578 1,970 3,008 2,624
Depreciation Expense
530 550 1,103 1,486 1,418 1,317 1,105 1,061 1,087 1,136 1,188
Non-Cash Adjustments To Reconcile Net Income
2,080 0.00 11 153 245 15,355 1,057 1,089 -398 -165 306
Changes in Operating Assets and Liabilities, net
-702 -473 -1,522 -160 192 393 542 316 403 -647 -308
Net Cash From Investing Activities
-466 -472 -4,123 -578 -1,045 -618 -463 -1,564 -817 -1,016 -2,044
Net Cash From Continuing Investing Activities
-466 -472 -4,123 -578 -1,045 -618 -463 -1,564 -817 -1,016 -2,044
Purchase of Property, Plant & Equipment
-607 -424 -665 -995 -1,240 -974 -856 -989 -1,224 -1,278 -1,273
Acquisitions
-86 -16 -3,375 -530 -176 -57 -87 -767 -301 0.00 -830
Sale of Property, Plant & Equipment
30 20 172 458 264 187 315 217 208 203 195
Divestitures
181 0.00 20 453 77 187 70 0.00 293 0.00 0.00
Sale and/or Maturity of Investments
- - - - - - 147 26 372 92 1.00
Other Investing Activities, net
16 -52 -275 36 30 39 -52 -51 -165 -33 -137
Net Cash From Financing Activities
-515 -102 10,919 -4,363 -1,534 225 -2,143 -1,592 -2,028 -1,527 -1,482
Net Cash From Continuing Financing Activities
-515 -102 10,919 -4,363 -1,534 225 -2,143 -1,592 -2,028 -1,527 -1,482
Repayment of Debt
193 -293 -1,024 -1,067 -1,064 469 -2,210 -38 -704 -207 -188
Repurchase of Common Equity
0.00 0.00 -477 -2,486 -250 0.00 -434 -828 -538 -484 -384
Payment of Dividends
0.00 0.00 -406 -810 -745 -744 -749 -726 -786 -836 -910
Effect of Exchange Rate Changes
-254 -139 - -128 -21 -28 -47 -97 -59 -71 67
Cash Interest Paid
52 55 109 - - - - 291 309 298 294
Cash Income Taxes Paid
264 317 230 - - - - 498 595 1,040 1,156

Quarterly Cash Flow Statements for Baker Hughes

This table details how cash moves in and out of Baker Hughes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
396 -555 71 -433 380 700 -87 -190 -394 1,022 11,049
Net Cash From Operating Activities
810 932 784 348 1,010 1,190 709 510 929 1,662 500
Net Cash From Continuing Operating Activities
810 932 784 348 1,010 1,190 709 510 929 1,662 500
Net Income / (Loss) Continuing Operations
524 451 463 581 773 1,191 409 711 617 887 938
Consolidated Net Income / (Loss)
524 451 463 581 773 1,191 409 711 617 887 938
Depreciation Expense
268 274 283 283 278 292 285 294 282 327 354
Non-Cash Adjustments To Reconcile Net Income
-39 49 -1.00 31 -47 -71 190 -67 59 124 -626
Changes in Operating Assets and Liabilities, net
57 158 39 -547 6.00 -222 -175 -428 -29 324 -166
Net Cash From Investing Activities
-89 -314 -269 -261 -269 -217 -310 -286 -1,055 -393 1,038
Net Cash From Continuing Investing Activities
-89 -314 -269 -261 -269 -217 -310 -286 -1,055 -393 1,038
Purchase of Property, Plant & Equipment
-281 -356 -333 -292 -300 -353 -300 -301 -295 -377 -336
Sale of Property, Plant & Equipment
63 58 51 50 44 58 45 29 65 56 46
Divestitures
- - 0.00 - - - 0.00 - - - 1,381
Other Investing Activities, net
-224 -16 13 -19 -34 7.00 -55 -14 -26 -42 -53
Net Cash From Financing Activities
-311 -1,167 -427 -502 -364 -234 -502 -443 -279 -258 9,523
Net Cash From Continuing Financing Activities
-311 -1,167 -427 -502 -364 -234 -502 -443 -279 -258 9,523
Repayment of Debt
11 -648 -59 -127 -3.00 -18 -85 -20 -52 -31 -134
Repurchase of Common Equity
-120 -319 -158 -166 -152 -8.00 -188 -196 - - 0.00
Payment of Dividends
-202 -200 -210 -209 -209 -208 -229 -227 -227 -227 -228
Issuance of Debt
- - - - - - 0.00 - - - 9,885
Effect of Exchange Rate Changes
-14 -6.00 -17 -18 3.00 -39 16 29 11 11 -12
Cash Interest Paid
48 104 48 102 49 99 50 98 49 97 56
Cash Income Taxes Paid
140 132 108 228 397 307 207 211 336 402 188

Annual Balance Sheets for Baker Hughes

This table presents Baker Hughes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
21,721 56,500 52,439 53,369 38,007 35,308 34,181 36,945 38,363 40,881
Total Current Assets
7,401 18,424 14,971 15,222 16,455 15,065 14,592 16,301 17,211 18,828
Cash & Equivalents
981 - - - 4,132 - 2,488 2,646 3,364 3,715
Accounts Receivable
2,563 6,015 5,969 6,416 5,622 5,651 5,958 7,075 7,122 6,641
Inventories, net
3,224 4,507 4,620 4,608 4,421 3,979 4,587 5,094 4,954 4,954
Other Current Assets
633 872 659 949 2,280 1,582 1,559 1,486 1,771 3,518
Plant, Property, & Equipment, net
2,325 6,959 6,228 6,240 5,358 4,877 4,538 4,893 5,127 5,326
Total Noncurrent Assets
11,995 31,117 31,240 31,907 16,194 15,366 15,051 15,751 16,025 16,727
Goodwill
6,680 19,927 20,717 20,690 5,977 5,959 5,930 6,137 6,078 6,068
Intangible Assets
2,449 6,358 5,719 5,381 4,397 4,131 4,180 4,093 3,951 4,097
Noncurrent Deferred & Refundable Income Taxes
326 715 1,072 954 953 735 657 722 1,284 1,957
Other Noncurrent Operating Assets
2,540 4,117 3,732 4,882 4,867 4,541 4,284 4,799 4,712 4,605
Total Liabilities & Shareholders' Equity
21,721 56,500 52,439 53,369 38,007 35,308 34,181 36,945 38,363 40,881
Total Liabilities
6,866 18,090 17,426 18,870 19,765 18,562 19,656 21,426 21,308 21,871
Total Current Liabilities
4,934 9,227 9,020 10,014 10,227 9,128 11,075 12,991 12,991 13,877
Short-Term Debt
239 2,037 942 321 889 40 677 148 53 689
Accounts Payable
1,898 3,377 4,025 4,268 3,532 3,745 4,298 4,471 4,542 4,579
Current Deferred Revenue
1,596 1,775 1,765 2,870 3,454 3,232 3,822 5,542 5,672 5,904
Other Current Liabilities
1,201 2,038 2,288 2,555 2,352 2,111 2,278 2,830 2,724 2,705
Total Noncurrent Liabilities
1,932 8,863 8,406 8,856 9,538 9,434 8,581 8,435 8,317 7,994
Long-Term Debt
38 6,312 6,285 6,301 6,744 6,687 5,980 5,872 5,970 5,398
Noncurrent Deferred & Payable Income Tax Liabilities
880 490 143 51 186 127 229 176 83 84
Noncurrent Employee Benefit Liabilities
519 1,172 1,018 1,079 1,217 1,110 960 978 988 1,066
Other Noncurrent Operating Liabilities
495 889 960 1,425 1,391 1,510 1,412 1,409 1,276 1,446
Total Equity & Noncontrolling Interests
14,855 38,410 35,013 34,499 18,242 16,746 14,525 15,519 17,055 19,010
Total Preferred & Common Equity
14,688 14,277 17,465 21,929 12,893 14,830 14,394 15,368 16,895 18,834
Total Common Equity
14,688 14,277 17,465 21,929 12,893 14,830 14,394 15,368 16,895 18,834
Common Stock
0.00 15,083 18,659 23,565 24,613 27,375 28,126 26,983 25,896 24,738
Retained Earnings
0.00 -103 25 0.00 -9,942 -10,160 -10,761 -8,819 -5,840 -3,252
Accumulated Other Comprehensive Income / (Loss)
-1,894 -703 -1,219 -1,636 -1,778 -2,385 -2,971 -2,796 -3,161 -2,652
Noncontrolling Interest
167 24,133 17,548 12,570 5,349 1,916 131 151 160 176

Quarterly Balance Sheets for Baker Hughes

This table presents Baker Hughes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
36,093 36,550 36,945 37,141 36,656 37,530 38,363 38,110 38,740 39,233 50,896
Total Current Assets
15,806 16,161 16,301 16,420 15,930 16,568 17,211 16,841 17,618 17,529 28,591
Cash & Equivalents
2,805 3,201 2,646 2,717 2,284 2,664 3,364 3,277 3,087 2,693 14,764
Accounts Receivable
6,418 6,505 7,075 6,873 7,051 6,920 7,122 6,710 6,511 6,555 6,696
Inventories, net
4,957 4,964 5,094 5,339 5,126 5,254 4,954 5,161 5,105 5,036 4,868
Other Current Assets
1,626 1,491 1,486 1,491 1,469 1,730 1,771 1,693 2,915 3,245 2,263
Plant, Property, & Equipment, net
4,723 4,768 4,893 4,931 4,951 5,150 5,127 5,168 5,176 5,264 5,540
Total Noncurrent Assets
15,564 15,621 15,751 15,790 15,775 15,812 16,025 16,101 15,946 16,440 16,765
Goodwill
6,074 6,048 6,137 6,114 6,105 6,167 6,078 6,126 5,801 6,051 6,032
Intangible Assets
4,124 4,104 4,093 4,055 4,019 3,995 3,951 3,927 3,919 4,180 4,073
Noncurrent Deferred & Refundable Income Taxes
670 687 722 730 676 649 1,284 1,363 1,371 1,410 1,729
Other Noncurrent Operating Assets
4,696 4,782 4,799 4,891 4,975 5,001 4,712 4,685 4,855 4,799 4,931
Total Liabilities & Shareholders' Equity
36,093 36,550 36,945 37,141 36,656 37,530 38,363 38,110 38,740 39,233 50,896
Total Liabilities
20,831 21,155 21,426 21,591 20,935 21,187 21,308 20,904 20,872 20,905 31,406
Total Current Liabilities
12,311 12,681 12,991 13,179 12,586 12,790 12,991 12,594 12,515 12,438 13,413
Short-Term Debt
797 802 148 147 34 52 53 55 66 68 753
Accounts Payable
4,154 4,123 4,471 4,595 4,649 4,431 4,542 4,465 4,340 4,196 4,257
Current Deferred Revenue
5,101 5,187 5,542 5,711 5,506 5,685 5,672 5,589 5,680 5,511 5,999
Other Current Liabilities
2,259 2,569 2,830 2,726 2,397 2,622 2,724 2,485 2,429 2,663 2,404
Total Noncurrent Liabilities
8,520 8,474 8,435 8,412 8,349 8,397 8,317 8,310 8,357 8,467 17,993
Long-Term Debt
5,847 5,857 5,872 5,859 5,861 5,984 5,970 5,969 5,968 5,988 15,411
Noncurrent Deferred & Payable Income Tax Liabilities
283 280 176 149 156 154 83 93 106 116 94
Noncurrent Employee Benefit Liabilities
968 952 978 984 984 991 988 985 997 1,024 1,041
Other Noncurrent Operating Liabilities
1,422 1,385 1,409 1,420 1,348 1,268 1,276 1,263 1,286 1,339 1,447
Total Equity & Noncontrolling Interests
15,262 15,395 15,519 15,550 15,721 16,343 17,055 17,206 17,868 18,328 19,490
Total Preferred & Common Equity
15,125 15,250 15,368 15,391 15,574 16,189 16,895 17,042 17,697 18,157 19,314
Total Common Equity
15,125 15,250 15,368 15,391 15,574 16,189 16,895 17,042 17,697 18,157 19,314
Common Stock
27,696 27,415 26,983 26,610 26,340 26,045 25,896 25,450 25,087 24,935 24,480
Retained Earnings
-9,776 -9,258 -8,819 -8,364 -7,785 -7,019 -5,840 -5,438 -4,737 -4,128 -2,322
Accumulated Other Comprehensive Income / (Loss)
-2,795 -2,907 -2,796 -2,855 -2,981 -2,837 -3,161 -2,970 -2,653 -2,650 -2,844
Noncontrolling Interest
137 145 151 159 147 154 160 164 171 171 176

Annual Metrics And Ratios for Baker Hughes

This table displays calculated financial ratios and metrics derived from Baker Hughes' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% -21.61% 31.32% 33.17% 4.20% -13.14% -0.98% 3.19% 20.56% 9.11% -0.35%
EBITDA Growth
0.00% 105.28% -10.99% 165.74% 0.80% -665.66% 113.45% -27.13% 196.48% 16.20% -6.78%
EBIT Growth
0.00% 1,310.53% -144.35% 542.65% 9.63% -1,608.89% 104.87% -62.31% 947.81% 20.62% -10.51%
NOPAT Growth
0.00% 344.47% -184.18% 318.83% -11.15% -2,993.62% 90.97% -2,982.35% 105.52% 65.10% 5.97%
Net Income Growth
0.00% 129.32% -311.35% 172.38% -4.24% -5,915.87% 97.91% -75.15% 440.83% 52.69% -12.77%
EPS Growth
0.00% 0.00% 0.00% 287.50% -48.89% -6,504.35% 98.17% -125.93% 413.11% 56.02% 0.00%
Operating Cash Flow Growth
0.00% -79.48% -404.96% 320.53% 20.66% -38.66% 82.06% -20.47% 62.18% 8.82% 14.35%
Free Cash Flow Firm Growth
0.00% 0.00% -85.25% 106.39% -37.37% 379.33% -77.49% -2,814.15% 105.03% 32.71% -32.85%
Invested Capital Growth
0.00% 0.00% 180.75% -3.05% -1.67% -42.59% -9.76% -4.72% 1.06% 4.35% 8.46%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 2.08% 0.35% -3.95% -0.05% 2.03% 3.78% 1.94% 0.08%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 32.94% -6.34% 7.94% -31.49% -22.65% 4.68% 6.90% -5.84%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 225.99% -14.14% 7.55% -52.64% -57.65% 5.82% 8.76% -8.85%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 213.73% -34.07% -0.93% -586.05% -2,309.02% 7.25% 22.20% 1.14%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 385.86% -43.42% 5.16% -215.79% -34.42% 15.41% 32.57% -10.35%
EPS Q/Q Growth
0.00% 0.00% 0.00% 104.55% -48.89% 8.68% -133.75% -35.56% 10.40% 33.63% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -524.22% 283.88% 14.42% -42.91% 20.08% 7.03% 1.12% 8.39% 14.14%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -1.03% -25.95% -8.08% -7,456.05% 65.06% 38.11% 33.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -1.47% -1.97% 4.15% -1.28% 2.88% 0.21% -0.01% -1.42%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
26.94% 22.41% 17.67% 17.42% 18.59% 15.45% 19.75% 20.80% 20.59% 20.99% 23.60%
EBITDA Margin
2.95% 7.72% 5.23% 10.44% 10.10% -65.79% 8.94% 6.31% 15.52% 16.53% 15.46%
Operating Margin
-0.83% 3.49% -1.65% 3.06% 4.51% -77.17% 6.39% 5.60% 9.08% 11.07% 12.05%
EBIT Margin
-0.23% 3.52% -1.19% 3.95% 4.15% -72.15% 3.55% 1.30% 11.26% 12.44% 11.17%
Profit (Net Income) Margin
-3.78% 1.41% -2.28% 1.24% 1.14% -76.12% -1.61% -2.73% 7.72% 10.81% 9.46%
Tax Burden Percent
399.37% 51.68% 116.72% 41.62% 35.99% 103.68% -77.10% -2,627.27% 74.20% 92.13% 91.21%
Interest Burden Percent
415.79% 77.83% 164.22% 75.30% 76.06% 101.77% 58.87% 8.03% 92.48% 94.28% 92.84%
Effective Tax Rate
0.00% 48.32% 0.00% 37.94% 64.01% 0.00% 177.10% 2,727.27% 25.80% 7.87% 8.79%
Return on Invested Capital (ROIC)
0.00% 3.34% -0.74% 1.11% 1.01% -37.52% -4.88% -162.52% 9.15% 14.70% 14.83%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 17.87% -63.24% -5.19% -2.35% -170.67% 16.45% 705.16% 15.80% 20.32% -2.03%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.85% -0.73% -0.34% -0.23% -22.24% 3.00% 158.82% 3.97% 3.76% -0.28%
Return on Equity (ROE)
0.00% 2.49% -1.47% 0.77% 0.78% -59.77% -1.89% -3.70% 13.11% 18.47% 14.55%
Cash Return on Invested Capital (CROIC)
0.00% -196.66% -95.68% 4.21% 2.70% 16.59% 5.38% -157.68% 8.09% 10.45% 6.72%
Operating Return on Assets (OROA)
0.00% 2.12% -0.52% 1.66% 1.87% -32.70% 1.98% 0.79% 8.07% 9.20% 7.82%
Return on Assets (ROA)
0.00% 0.85% -1.00% 0.52% 0.51% -34.50% -0.90% -1.66% 5.54% 7.99% 6.62%
Return on Common Equity (ROCE)
0.00% 2.46% -0.80% 0.33% 0.44% -39.46% -1.49% -3.45% 12.99% 18.29% 14.42%
Return on Equity Simple (ROE_SIMPLE)
0.00% 1.26% -2.74% 1.62% 1.24% -122.24% -2.23% -4.02% 12.82% 17.80% 0.00%
Net Operating Profit after Tax (NOPAT)
-97 236 -199 435 387 -11,185 -1,010 -31,133 1,719 2,838 3,048
NOPAT Margin
-0.58% 1.81% -1.16% 1.90% 1.62% -54.02% -4.93% -147.16% 6.74% 10.20% 10.99%
Net Nonoperating Expense Percent (NNEP)
0.00% -14.53% 62.50% 6.30% 3.36% 133.15% -21.33% -867.68% -6.65% -5.62% 16.86%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -146.98% 7.98% 12.30% 12.15%
Cost of Revenue to Revenue
73.06% 77.59% 82.33% 82.58% 81.41% 84.55% 80.25% 79.20% 79.41% 79.01% 76.40%
SG&A Expenses to Revenue
12.67% 14.72% 14.76% 11.80% 11.88% 11.61% 12.05% 11.86% 10.24% 8.83% 8.61%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.16%
Operating Expenses to Revenue
27.76% 18.92% 19.33% 14.36% 14.09% 91.97% 13.36% 15.20% 11.50% 9.91% 11.55%
Earnings before Interest and Taxes (EBIT)
-38 460 -204 903 990 -14,938 727 274 2,871 3,463 3,099
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
492 1,010 899 2,389 2,408 -13,621 1,832 1,335 3,958 4,599 4,287
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.11 1.15 1.05 1.53 1.59 1.97 2.18 2.40 2.39
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 7.84 4.97 6.61 6.53 5.91 5.18
Price to Revenue (P/Rev)
0.00 0.00 1.75 0.88 0.97 0.95 1.15 1.34 1.31 1.46 1.62
Price to Earnings (P/E)
0.00 0.00 0.00 103.14 180.53 0.00 0.00 0.00 17.26 13.63 17.36
Dividend Yield
0.00% 0.00% 67.92% 3.94% 4.00% 3.77% 3.17% 2.60% 2.34% 2.05% 2.02%
Earnings Yield
0.00% 0.00% 0.00% 0.97% 0.55% 0.00% 0.00% 0.00% 5.80% 7.34% 5.76%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.40 1.07 1.03 1.32 1.44 1.75 1.96 2.20 2.22
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 3.23 1.80 1.64 1.38 1.38 1.54 1.45 1.56 1.71
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 61.79 17.23 16.22 0.00 15.47 24.45 9.36 9.44 11.08
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 45.59 39.45 0.00 38.98 119.11 12.91 12.54 15.32
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 94.63 101.03 0.00 0.00 0.00 21.55 15.29 15.58
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 23.36 18.37 21.94 11.94 17.29 12.10 13.03 12.46
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 24.99 37.86 5.79 25.46 0.00 24.37 21.52 34.41
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.02 0.22 0.21 0.19 0.42 0.40 0.46 0.39 0.35 0.32
Long-Term Debt to Equity
0.00 0.00 0.16 0.18 0.18 0.37 0.40 0.41 0.38 0.35 0.28
Financial Leverage
0.00 -0.05 0.01 0.07 0.10 0.13 0.18 0.23 0.25 0.19 0.14
Leverage Ratio
0.00 1.46 1.47 1.48 1.52 1.73 2.10 2.22 2.37 2.31 2.20
Compound Leverage Factor
0.00 1.14 2.41 1.12 1.16 1.76 1.23 0.18 2.19 2.18 2.04
Debt to Total Capital
0.00% 1.83% 17.86% 17.11% 16.10% 29.50% 28.66% 31.43% 27.95% 26.10% 24.25%
Short-Term Debt to Total Capital
0.00% 1.58% 4.36% 2.23% 0.78% 3.44% 0.17% 3.20% 0.69% 0.23% 2.75%
Long-Term Debt to Total Capital
0.00% 0.25% 13.50% 14.88% 15.32% 26.06% 28.49% 28.23% 27.26% 25.87% 21.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.10% 51.61% 41.54% 30.57% 20.67% 8.16% 0.62% 0.70% 0.69% 0.70%
Common Equity to Total Capital
0.00% 97.07% 30.53% 41.35% 53.33% 49.83% 63.18% 67.95% 71.35% 73.21% 75.04%
Debt to EBITDA
0.00 0.27 9.29 3.03 2.75 -0.56 3.67 4.99 1.52 1.31 1.42
Net Debt to EBITDA
0.00 -0.70 1.47 1.47 1.40 -0.26 1.57 3.12 0.85 0.58 0.55
Long-Term Debt to EBITDA
0.00 0.04 7.02 2.63 2.62 -0.50 3.65 4.48 1.48 1.30 1.26
Debt to NOPAT
0.00 1.17 -42.00 16.61 17.13 -0.68 -6.66 -0.21 3.50 2.12 2.00
Net Debt to NOPAT
0.00 -2.98 -6.63 8.05 8.73 -0.31 -2.85 -0.13 1.96 0.94 0.78
Long-Term Debt to NOPAT
0.00 0.16 -31.75 14.45 16.30 -0.60 -6.62 -0.19 3.42 2.10 1.77
Altman Z-Score
0.00 0.00 1.48 1.32 1.36 -0.32 1.21 1.19 1.66 2.09 2.20
Noncontrolling Interest Sharing Ratio
0.00% 1.12% 45.62% 56.77% 43.33% 33.98% 20.76% 6.55% 0.94% 0.95% 0.93%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 1.50 2.00 1.66 1.52 1.61 1.65 1.32 1.25 1.32 1.36
Quick Ratio
0.00 0.72 0.65 0.66 0.64 0.95 0.62 0.76 0.75 0.81 0.75
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -13,915 -25,777 1,647 1,032 4,944 1,113 -30,207 1,520 2,017 1,380
Operating Cash Flow to CapEx
221.32% 64.85% -162.07% 328.12% 217.83% 165.69% 438.82% 244.56% 301.38% 309.95% 353.43%
Free Cash Flow to Firm to Interest Expense
0.00 -136.42 -196.77 7.39 4.35 18.73 3.72 -119.87 7.04 10.19 6.22
Operating Cash Flow to Interest Expense
10.64 2.57 -6.10 7.90 8.97 4.94 7.94 7.49 14.18 16.83 17.16
Operating Cash Flow Less CapEx to Interest Expense
5.83 -1.39 -9.86 5.49 4.85 1.96 6.13 4.43 9.47 11.40 12.31
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.60 0.44 0.42 0.45 0.45 0.56 0.61 0.72 0.74 0.70
Accounts Receivable Turnover
0.00 5.10 4.01 3.82 3.85 3.44 3.64 3.64 3.91 3.92 4.03
Inventory Turnover
0.00 3.15 3.66 4.14 4.21 3.88 3.92 3.91 4.18 4.38 4.28
Fixed Asset Turnover
0.00 5.63 3.70 3.47 3.82 3.57 4.01 4.49 5.41 5.55 5.31
Accounts Payable Turnover
0.00 5.35 5.36 5.10 4.68 4.49 4.52 4.17 4.62 4.88 4.65
Days Sales Outstanding (DSO)
0.00 71.51 91.13 95.60 94.82 106.11 100.35 100.14 93.25 93.10 90.57
Days Inventory Outstanding (DIO)
0.00 115.94 99.76 88.17 86.78 94.13 93.17 93.30 87.23 83.39 85.34
Days Payable Outstanding (DPO)
0.00 68.25 68.07 71.51 77.99 81.32 80.72 87.60 79.01 74.80 78.56
Cash Conversion Cycle (CCC)
0.00 119.19 122.82 112.27 103.61 118.92 112.80 105.84 101.47 101.69 97.35
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 14,151 39,729 38,517 37,872 21,743 19,620 18,694 18,893 19,714 21,382
Invested Capital Turnover
0.00 1.85 0.64 0.58 0.62 0.69 0.99 1.10 1.36 1.44 1.35
Increase / (Decrease) in Invested Capital
0.00 14,151 25,578 -1,212 -645 -16,129 -2,123 -926 199 821 1,668
Enterprise Value (EV)
0.00 0.00 55,553 41,165 39,051 28,609 28,340 32,636 37,052 43,409 47,486
Market Capitalization
0.00 0.00 30,101 20,113 23,108 19,759 23,550 28,336 33,527 40,590 44,938
Book Value per Share
$0.00 $0.00 $12.47 $15.88 $21.35 $12.45 $14.31 $14.27 $15.27 $17.07 $19.09
Tangible Book Value per Share
$0.00 $0.00 ($10.48) ($8.16) ($4.03) $2.43 $4.57 $4.25 $5.11 $6.94 $8.79
Total Capital
0.00 15,132 46,759 42,240 41,121 25,875 23,473 21,182 21,539 23,078 25,097
Total Debt
0.00 277 8,349 7,227 6,622 7,633 6,727 6,657 6,020 6,023 6,087
Total Long-Term Debt
0.00 38 6,312 6,285 6,301 6,744 6,687 5,980 5,872 5,970 5,398
Net Debt
0.00 -704 1,319 3,504 3,373 3,501 2,874 4,169 3,374 2,659 2,372
Capital Expenditures (CapEx)
577 404 493 537 976 787 541 772 1,016 1,075 1,078
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 1,725 4,204 3,170 2,280 2,985 2,124 1,706 812 909 1,925
Debt-free Net Working Capital (DFNWC)
0.00 2,706 11,234 6,893 5,529 7,117 5,977 4,194 3,458 4,273 5,640
Net Working Capital (NWC)
0.00 2,467 9,197 5,951 5,208 6,228 5,937 3,517 3,310 4,220 4,951
Net Nonoperating Expense (NNE)
534 51 192 152 116 4,576 -680 -30,555 -251 -170 424
Net Nonoperating Obligations (NNO)
0.00 -704 1,319 3,504 3,373 3,501 2,874 4,169 3,374 2,659 2,372
Total Depreciation and Amortization (D&A)
530 550 1,103 1,486 1,418 1,317 1,105 1,061 1,087 1,136 1,188
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 13.19% 24.47% 13.86% 9.56% 14.42% 10.36% 8.06% 3.18% 3.27% 6.94%
Debt-free Net Working Capital to Revenue
0.00% 20.68% 65.39% 30.13% 23.19% 34.37% 29.15% 19.82% 13.56% 15.35% 20.34%
Net Working Capital to Revenue
0.00% 18.86% 53.54% 26.01% 21.85% 30.08% 28.96% 16.62% 12.98% 15.16% 17.85%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.34) $0.46 $0.23 ($14.73) ($0.27) ($0.61) $1.93 $3.00 $2.62
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.13B 1.04B 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M 988.24M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.34) $0.45 $0.23 ($14.73) ($0.27) ($0.61) $1.91 $2.98 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.13B 1.04B 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M 988.24M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($0.34) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.13B 1.04B 1.03B 1.04B 2.05B 1.01B 1.00B 990.11M 988.24M
Normalized Net Operating Profit after Tax (NOPAT)
1,666 520 351 799 991 463 1,105 1,323 1,959 3,116 3,244
Normalized NOPAT Margin
9.98% 3.97% 2.04% 3.49% 4.16% 2.23% 5.39% 6.25% 7.68% 11.20% 11.70%
Pre Tax Income Margin
-0.95% 2.74% -1.95% 2.97% 3.16% -73.42% 2.09% 0.10% 10.41% 11.73% 10.37%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.32 4.51 -1.56 4.05 4.18 -56.58 2.43 1.09 13.29 17.49 13.96
NOPAT to Interest Expense
-0.81 2.32 -1.52 1.95 1.63 -42.37 -3.38 -123.54 7.96 14.34 13.73
EBIT Less CapEx to Interest Expense
-5.13 0.55 -5.32 1.64 0.06 -59.56 0.62 -1.98 8.59 12.06 9.10
NOPAT Less CapEx to Interest Expense
-5.61 -1.65 -5.28 -0.46 -2.49 -45.35 -5.19 -126.61 3.26 8.91 8.87
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% -103.84% 286.22% 274.91% -4.72% -226.97% -125.61% 39.90% 27.79% 34.68%
Augmented Payout Ratio
0.00% 0.00% -225.83% 1,164.66% 367.16% -4.72% -358.48% -268.86% 67.21% 43.88% 49.31%

Quarterly Metrics And Ratios for Baker Hughes

This table displays calculated financial ratios and metrics derived from Baker Hughes' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 988,236,510.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 988,236,510.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.94
Growth Metrics
- - - - - - - - - - -
Revenue Growth
23.69% 15.73% 12.28% 13.05% 4.02% 7.76% 0.14% -3.21% 1.48% 0.30% 2.49%
EBITDA Growth
131.90% 26.66% -11.71% 21.73% 24.72% 35.32% -2.61% 13.95% -13.64% -22.50% 91.08%
EBIT Growth
286.60% 38.63% -17.23% 29.61% 31.68% 49.21% -4.08% 17.22% -17.58% -33.82% 122.22%
NOPAT Growth
3,031.94% 56.37% 40.86% 69.47% 44.73% 77.87% 15.00% 9.46% -0.13% 22.72% 3.67%
Net Income Growth
5,922.22% 139.89% -20.31% 40.34% 47.71% 163.86% -11.66% 22.38% -20.28% -25.46% 129.34%
EPS Growth
2,650.00% 72.00% -21.05% 45.00% 50.98% 174.42% -11.11% 22.41% -20.78% 0.00% 132.50%
Operating Cash Flow Growth
35.68% 3.79% 70.07% -59.49% 24.69% 27.68% -9.57% 46.55% -8.02% 39.66% -29.48%
Free Cash Flow Firm Growth
-111.21% -71.73% -38.65% 469.49% 21.40% -50.63% -177.42% -327.74% -750.30% -288.04% 34.85%
Invested Capital Growth
3.75% 1.06% -1.33% 1.21% 4.57% 4.35% 5.91% 7.67% 10.02% 8.46% 4.70%
Revenue Q/Q Growth
5.16% 2.91% -6.09% 11.23% -3.24% 6.60% -12.72% 7.52% 1.45% 5.36% -10.82%
EBITDA Q/Q Growth
13.50% -21.84% 14.74% 19.59% 16.29% -15.20% -21.18% 46.60% -11.86% -20.97% 87.12%
EBIT Q/Q Growth
20.24% -29.83% 20.28% 27.71% 22.16% -20.49% -27.66% 66.83% -14.10% -32.84% 130.90%
NOPAT Q/Q Growth
42.23% 14.10% -16.14% 24.53% 21.46% 40.24% -45.20% 18.96% 9.24% 78.03% -55.19%
Net Income Q/Q Growth
26.57% -13.93% 2.66% 25.49% 33.22% 53.75% -65.63% 73.84% -13.22% 43.76% 5.75%
EPS Q/Q Growth
27.50% -15.69% -55.00% 28.89% 32.76% 53.25% -66.10% 77.50% -14.08% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-5.70% 15.06% -15.88% -55.61% 190.23% 17.82% -40.42% -28.07% 82.16% 78.90% -69.92%
Free Cash Flow Firm Q/Q Growth
-402.15% 292.24% 99.66% -50.89% -141.70% 220.75% -415.28% -46.85% -52.09% 68.37% 7.77%
Invested Capital Q/Q Growth
-1.30% 0.21% -0.29% 2.62% 1.98% -0.01% 1.21% 4.32% 4.21% -1.42% -2.30%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.22% 21.19% 19.91% 20.87% 22.32% 20.78% 22.95% 23.37% 24.27% 23.73% 22.83%
EBITDA Margin
16.20% 12.31% 15.04% 16.16% 19.43% 15.45% 13.96% 19.03% 16.53% 12.40% 26.02%
Operating Margin
10.75% 9.53% 10.17% 11.67% 13.46% 9.03% 11.70% 12.84% 13.52% 10.22% 11.72%
EBIT Margin
12.17% 8.30% 10.63% 12.20% 15.40% 11.49% 9.52% 14.78% 12.51% 7.97% 20.65%
Profit (Net Income) Margin
7.89% 6.60% 7.21% 8.14% 11.20% 16.16% 6.36% 10.29% 8.80% 12.01% 14.24%
Tax Burden Percent
69.04% 86.40% 72.23% 70.51% 76.71% 150.44% 72.91% 73.53% 75.15% 167.99% 73.63%
Interest Burden Percent
93.94% 92.06% 93.99% 94.60% 94.83% 93.50% 91.67% 94.71% 93.61% 89.64% 93.68%
Effective Tax Rate
30.96% 13.60% 27.77% 29.49% 23.29% -50.44% 27.09% 26.47% 24.85% -67.99% 26.37%
Return on Invested Capital (ROIC)
9.85% 11.17% 10.16% 11.57% 14.62% 19.59% 12.24% 12.98% 13.60% 23.18% 11.79%
ROIC Less NNEP Spread (ROIC-NNEP)
10.71% 8.21% 9.93% 11.40% 16.39% 25.87% 7.63% 14.78% 10.77% 8.02% 29.61%
Return on Net Nonoperating Assets (RNNOA)
2.61% 2.06% 2.46% 2.74% 3.53% 4.79% 1.41% 2.88% 2.09% 1.12% 3.35%
Return on Equity (ROE)
12.47% 13.23% 12.61% 14.32% 18.15% 24.38% 13.65% 15.87% 15.70% 24.30% 15.13%
Cash Return on Invested Capital (CROIC)
4.98% 8.09% 11.09% 9.71% 7.58% 10.45% 9.43% 7.45% 5.01% 6.72% 9.87%
Operating Return on Assets (OROA)
8.58% 5.95% 7.72% 9.07% 11.35% 8.49% 7.05% 10.82% 9.03% 5.58% 12.94%
Return on Assets (ROA)
5.56% 4.73% 5.24% 6.05% 8.26% 11.94% 4.71% 7.54% 6.35% 8.41% 8.93%
Return on Common Equity (ROCE)
12.31% 13.11% 12.49% 14.18% 17.98% 24.14% 13.51% 15.72% 15.55% 24.07% 14.99%
Return on Equity Simple (ROE_SIMPLE)
11.19% 0.00% 12.03% 12.96% 14.02% 0.00% 17.33% 17.43% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
493 562 472 587 713 1,000 548 652 712 1,268 568
NOPAT Margin
7.42% 8.23% 7.35% 8.23% 10.33% 13.59% 8.53% 9.44% 10.16% 17.17% 8.63%
Net Nonoperating Expense Percent (NNEP)
-0.86% 2.96% 0.23% 0.17% -1.77% -6.28% 4.61% -1.79% 2.83% 15.16% -17.83%
Return On Investment Capital (ROIC_SIMPLE)
- 2.61% - - - 4.34% 2.36% 2.73% 2.92% 5.05% 1.59%
Cost of Revenue to Revenue
79.78% 78.81% 80.09% 79.13% 77.68% 79.22% 77.05% 76.63% 75.73% 76.27% 77.17%
SG&A Expenses to Revenue
9.44% 9.28% 9.63% 9.01% 8.86% 7.94% 8.98% 8.21% 8.66% 8.61% 8.53%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.27% 2.33% 2.08% 1.99% 2.02%
Operating Expenses to Revenue
9.47% 11.66% 9.74% 9.20% 8.86% 11.75% 11.25% 10.54% 10.74% 13.51% 11.11%
Earnings before Interest and Taxes (EBIT)
808 567 682 871 1,064 846 612 1,021 877 589 1,360
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,076 841 965 1,154 1,342 1,138 897 1,315 1,159 916 1,714
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.28 2.18 2.19 2.25 2.22 2.40 2.55 2.15 2.65 2.39 3.12
Price to Tangible Book Value (P/TBV)
6.82 6.53 6.46 6.44 5.96 5.91 6.23 4.76 6.06 5.18 6.55
Price to Revenue (P/Rev)
1.41 1.31 1.29 1.30 1.32 1.46 1.56 1.38 1.73 1.62 2.16
Price to Earnings (P/E)
20.60 17.26 18.50 17.63 16.04 13.63 14.87 12.46 16.61 17.36 19.36
Dividend Yield
2.24% 2.34% 2.39% 2.87% 2.30% 2.05% 1.96% 2.30% 1.85% 2.02% 1.51%
Earnings Yield
4.85% 5.80% 5.41% 5.67% 6.23% 7.34% 6.72% 8.02% 6.02% 5.76% 5.16%
Enterprise Value to Invested Capital (EV/IC)
2.03 1.96 1.97 2.01 2.00 2.20 2.33 1.97 2.38 2.22 2.96
Enterprise Value to Revenue (EV/Rev)
1.56 1.45 1.42 1.44 1.44 1.56 1.67 1.49 1.86 1.71 2.22
Enterprise Value to EBITDA (EV/EBITDA)
10.15 9.36 9.70 9.63 9.17 9.44 10.15 8.68 11.33 11.08 12.13
Enterprise Value to EBIT (EV/EBIT)
14.14 12.91 13.62 13.27 12.39 12.54 13.51 11.46 15.17 15.32 16.09
Enterprise Value to NOPAT (EV/NOPAT)
23.93 21.55 20.09 18.54 16.98 15.29 15.78 13.80 17.11 15.58 20.97
Enterprise Value to Operating Cash Flow (EV/OCF)
12.67 12.10 10.98 13.52 12.83 13.03 14.25 12.02 15.45 12.46 17.19
Enterprise Value to Free Cash Flow (EV/FCFF)
41.65 24.37 17.67 20.83 27.00 21.52 25.39 27.47 49.69 34.41 30.71
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.43 0.39 0.39 0.38 0.37 0.35 0.35 0.34 0.33 0.32 0.83
Long-Term Debt to Equity
0.38 0.38 0.38 0.37 0.37 0.35 0.35 0.33 0.33 0.28 0.79
Financial Leverage
0.24 0.25 0.25 0.24 0.22 0.19 0.18 0.20 0.19 0.14 0.11
Leverage Ratio
2.34 2.37 2.37 2.35 2.33 2.31 2.30 2.24 2.21 2.20 2.43
Compound Leverage Factor
2.20 2.18 2.23 2.22 2.21 2.16 2.11 2.13 2.07 1.97 2.27
Debt to Total Capital
30.19% 27.95% 27.86% 27.27% 26.97% 26.10% 25.93% 25.24% 24.84% 24.25% 45.34%
Short-Term Debt to Total Capital
3.64% 0.69% 0.68% 0.16% 0.23% 0.23% 0.24% 0.28% 0.28% 2.75% 2.11%
Long-Term Debt to Total Capital
26.56% 27.26% 27.18% 27.11% 26.74% 25.87% 25.70% 24.97% 24.56% 21.51% 43.22%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.66% 0.70% 0.74% 0.68% 0.69% 0.69% 0.71% 0.72% 0.70% 0.70% 0.49%
Common Equity to Total Capital
69.15% 71.35% 71.40% 72.05% 72.34% 73.21% 73.36% 74.04% 74.46% 75.04% 54.17%
Debt to EBITDA
1.76 1.52 1.57 1.46 1.40 1.31 1.32 1.27 1.33 1.42 3.17
Net Debt to EBITDA
0.91 0.85 0.86 0.89 0.78 0.58 0.60 0.62 0.74 0.55 0.27
Long-Term Debt to EBITDA
1.55 1.48 1.53 1.45 1.39 1.30 1.30 1.26 1.32 1.26 3.02
Debt to NOPAT
4.15 3.50 3.25 2.81 2.60 2.12 2.05 2.03 2.01 2.00 5.47
Net Debt to NOPAT
2.16 1.96 1.78 1.72 1.45 0.94 0.93 0.99 1.12 0.78 0.47
Long-Term Debt to NOPAT
3.65 3.42 3.17 2.80 2.58 2.10 2.03 2.00 1.99 1.77 5.22
Altman Z-Score
1.49 1.45 1.49 1.63 1.70 1.86 1.97 1.88 2.17 1.99 2.08
Noncontrolling Interest Sharing Ratio
1.24% 0.94% 0.97% 0.92% 0.94% 0.95% 0.99% 0.95% 0.94% 0.93% 0.93%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.27 1.25 1.25 1.27 1.30 1.32 1.34 1.41 1.41 1.36 2.13
Quick Ratio
0.77 0.75 0.73 0.74 0.75 0.81 0.79 0.77 0.74 0.75 1.60
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-189 363 726 356 -149 179 -566 -831 -1,264 -400 -369
Operating Cash Flow to CapEx
371.56% 312.75% 278.01% 143.80% 394.53% 403.39% 278.04% 187.50% 403.91% 517.76% 172.41%
Free Cash Flow to Firm to Interest Expense
-3.86 8.08 17.70 7.58 -2.70 3.26 -11.09 -15.39 -22.56 -6.55 -4.29
Operating Cash Flow to Interest Expense
16.53 20.71 19.12 7.40 18.36 21.64 13.90 9.44 16.59 27.25 5.81
Operating Cash Flow Less CapEx to Interest Expense
12.08 14.09 12.24 2.26 13.71 16.27 8.90 4.41 12.48 21.98 2.44
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.71 0.72 0.73 0.74 0.74 0.74 0.74 0.73 0.72 0.70 0.63
Accounts Receivable Turnover
4.07 3.91 3.98 4.01 4.07 3.92 4.10 4.07 4.11 4.03 4.16
Inventory Turnover
4.28 4.18 4.11 4.26 4.22 4.38 4.18 4.26 4.25 4.28 4.25
Fixed Asset Turnover
5.37 5.41 5.55 5.59 5.50 5.55 5.51 5.45 5.32 5.31 5.21
Accounts Payable Turnover
4.91 4.62 4.70 4.88 5.04 4.88 4.85 4.84 5.07 4.65 4.89
Days Sales Outstanding (DSO)
89.76 93.25 91.67 90.93 89.75 93.10 89.05 89.65 88.74 90.57 87.71
Days Inventory Outstanding (DIO)
85.20 87.23 88.72 85.70 86.57 83.39 87.24 85.78 85.88 85.34 85.85
Days Payable Outstanding (DPO)
74.39 79.01 77.62 74.82 72.47 74.80 75.28 75.37 72.00 78.56 74.66
Cash Conversion Cycle (CCC)
100.58 101.47 102.77 101.81 103.85 101.69 101.01 100.06 102.62 97.35 98.90
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
18,853 18,893 18,839 19,332 19,715 19,714 19,953 20,815 21,691 21,382 20,890
Invested Capital Turnover
1.33 1.36 1.38 1.41 1.42 1.44 1.44 1.38 1.34 1.35 1.37
Increase / (Decrease) in Invested Capital
682 199 -254 231 862 821 1,114 1,483 1,976 1,668 937
Enterprise Value (EV)
38,363 37,052 37,157 38,858 39,438 43,409 46,426 41,103 51,566 47,486 61,908
Market Capitalization
34,760 33,527 33,709 35,100 35,912 40,590 43,515 37,985 48,032 44,938 60,332
Book Value per Share
$15.10 $15.27 $15.42 $15.61 $16.30 $17.07 $17.21 $17.86 $18.42 $19.09 $19.54
Tangible Book Value per Share
$5.05 $5.11 $5.23 $5.46 $6.07 $6.94 $7.06 $8.05 $8.04 $8.79 $9.32
Total Capital
22,054 21,539 21,556 21,616 22,379 23,078 23,230 23,902 24,384 25,097 35,654
Total Debt
6,659 6,020 6,006 5,895 6,036 6,023 6,024 6,034 6,056 6,087 16,164
Total Long-Term Debt
5,857 5,872 5,859 5,861 5,984 5,970 5,969 5,968 5,988 5,398 15,411
Net Debt
3,458 3,374 3,289 3,611 3,372 2,659 2,747 2,947 3,363 2,372 1,400
Capital Expenditures (CapEx)
218 298 282 242 256 295 255 272 230 321 290
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,081 812 671 1,094 1,166 909 1,025 2,082 2,466 1,925 1,167
Debt-free Net Working Capital (DFNWC)
4,282 3,458 3,388 3,378 3,830 4,273 4,302 5,169 5,159 5,640 15,931
Net Working Capital (NWC)
3,480 3,310 3,241 3,344 3,778 4,220 4,247 5,103 5,091 4,951 15,178
Net Nonoperating Expense (NNE)
-31 111 8.67 6.35 -61 -190 139 -59 95 381 -370
Net Nonoperating Obligations (NNO)
3,458 3,374 3,289 3,611 3,372 2,659 2,747 2,947 3,363 2,372 1,400
Total Depreciation and Amortization (D&A)
268 274 283 283 278 292 285 294 282 327 354
Debt-free, Cash-free Net Working Capital to Revenue
4.40% 3.18% 2.56% 4.05% 4.27% 3.27% 3.68% 7.54% 8.90% 6.94% 4.18%
Debt-free Net Working Capital to Revenue
17.42% 13.56% 12.93% 12.50% 14.03% 15.35% 15.45% 18.72% 18.62% 20.34% 57.11%
Net Working Capital to Revenue
14.16% 12.98% 12.37% 12.37% 13.84% 15.16% 15.26% 18.48% 18.37% 17.85% 54.42%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.51 $0.44 $0.46 $0.58 $0.77 $1.19 $0.41 $0.71 $0.62 $0.88 $0.94
Adjusted Weighted Average Basic Shares Outstanding
1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M 986.77M 988.24M 992.07M
Adjusted Diluted Earnings per Share
$0.51 $0.43 $0.45 $0.58 $0.77 $1.18 $0.40 $0.71 $0.61 $0.00 $0.93
Adjusted Weighted Average Diluted Shares Outstanding
1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M 986.77M 988.24M 992.07M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.01B 1.00B 998.00M 993.42M 989.53M 990.11M 990.75M 985.88M 986.77M 988.24M 992.07M
Normalized Net Operating Profit after Tax (NOPAT)
494 703 477 597 713 662 548 652 712 529 596
Normalized NOPAT Margin
7.44% 10.29% 7.43% 8.37% 10.33% 8.98% 8.53% 9.44% 10.16% 7.16% 9.04%
Pre Tax Income Margin
11.43% 7.64% 9.99% 11.54% 14.61% 10.74% 8.73% 13.99% 11.71% 7.15% 19.34%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
16.49 12.60 16.63 18.53 19.35 15.38 12.00 18.91 15.66 9.66 15.81
NOPAT to Interest Expense
10.06 12.50 11.50 12.50 12.97 18.19 10.75 12.08 12.72 20.79 6.61
EBIT Less CapEx to Interest Expense
12.04 5.98 9.76 13.38 14.69 10.02 7.00 13.87 11.55 4.39 12.44
NOPAT Less CapEx to Interest Expense
5.61 5.88 4.63 7.35 8.32 12.83 5.75 7.04 8.62 15.53 3.24
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
46.46% 39.90% 43.41% 40.66% 36.49% 27.79% 28.94% 28.31% 30.44% 34.68% 28.83%
Augmented Payout Ratio
65.20% 67.21% 80.99% 78.45% 71.53% 43.88% 46.34% 45.95% 43.83% 49.31% 35.05%

Financials Breakdown Chart

Key Financial Trends

Baker Hughes (BKR) shows a constructive near-term trend in 2025 with rising revenue, stronger quarterly cash flow, and a modest dividend uplift, while maintaining relatively stable leverage. Here are the most notable takeaways from the latest four quarters and the broader four-year window.

  • Total Revenue in Q4 2025 was 7.386 billion, up slightly from 7.364 billion in Q4 2024 (approximately +0.3% YoY).
  • Gross Profit rose to 1.753 billion in Q4 2025, up from about 1.53 billion in Q4 2024, indicating improved profitability on a year-over-year basis.
  • Net cash from continuing operating activities was 1.662 billion in Q4 2025, up from 0.929 billion in Q3 2025, signaling stronger quarterly cash generation.
  • Net income attributable to common shareholders reached 876 million in Q4 2025, reflecting earnings momentum in the latest quarter.
  • Dividends per share increased to 0.23 in 2025, up from 0.21 in 2024, benefiting income-focused investors.
  • Long-term debt remained stable around 5.9–6.0 billion in 2025, indicating manageable leverage.
  • Total assets increased to roughly 39.2 billion by Q3 2025, signaling scale growth without an outsized rise in liabilities.
  • R&D spending stays around the mid-100 millions per quarter (roughly 146–161 million in 2025), indicating ongoing development investment consistent with product and service enhancements.
  • S.G.A. expense as a share of revenue ticked up in Q4 2025 (636 million on 7.386 billion revenue; ~8.6%), suggesting some margin pressure on lower-cost lines.
  • Other income/expense volatility remained a headwind in some quarters (for example, -227 million net in Q4 2025), which can weigh on pretax and net results.
05/22/26 10:18 PM ETAI Generated. May Contain Errors.

Baker Hughes Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Baker Hughes' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Baker Hughes' net income appears to be on a downward trend, with a most recent value of $2.62 billion in 2025, falling from -$631 million in 2015. The previous period was $3.01 billion in 2024. See where experts think Baker Hughes is headed by visiting Baker Hughes' forecast page.

Baker Hughes' total operating income in 2025 was $3.34 billion, based on the following breakdown:
  • Total Gross Profit: $6.54 billion
  • Total Operating Expenses: $3.20 billion

Over the last 10 years, Baker Hughes' total revenue changed from $16.69 billion in 2015 to $27.73 billion in 2025, a change of 66.2%.

Baker Hughes' total liabilities were at $21.87 billion at the end of 2025, a 2.6% increase from 2024, and a 218.5% increase since 2016.

In the past 9 years, Baker Hughes' cash and equivalents has ranged from $0.00 in 2017 to $4.13 billion in 2020, and is currently $3.72 billion as of their latest financial filing in 2025.

Over the last 10 years, Baker Hughes' book value per share changed from 0.00 in 2015 to 19.09 in 2025, a change of 1,908.6%.



Financial statements for NASDAQ:BKR last updated on 4/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners